Skip to content

Multicenter Clinical Study on the Long-term Safety and Efficacy of Surgery for Pathological Myopia

Multicenter Clinical Study on the Long-term Safety and Efficacy of Surgery for Pathological Myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127937
Enrollment
Unknown
Registered
2026-07-10
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High myopia

Interventions

Scleral Contraction Group:Scleral Contraction Surgery

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with high myopia (axial length = 26.5 mm or refractive error = -6.0 D) accompanied by progressive axial elongation or related fundus complications (such as posterior staphyloma, retinoschisis, retinal breaks, retinal detachment, etc.); 2. Aged 4–65 years, who voluntarily sign the informed consent form. 3. The ophthalmic examination shows posterior staphyloma.

Exclusion criteria

Exclusion criteria: 1. Patients with severe systemic diseases, active ocular inflammation; 2. Other conditions deemed inappropriate for enrollment by the investigator.

Design outcomes

Primary

MeasureTime frame
Axial length;

Secondary

MeasureTime frame
Best corrected visual acuity;Intraocular pressure;Anxiety and depression scale score;Retinal structure and morphology;Central visual field;

Countries

China

Contacts

Public ContactRuihua Wei

Tianjin Medical University Eye Hospital

weirhua2009@126.com+86 139 2068 5016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026